The preloaded, single-use Vagifem®10 mcg applicators come individually packaged in a blister pack and should be discarded after each use.2 WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, PROBABLE DEMENTIA, and BREAST CANCER Estrogen-Alone Therapy ...
Learn about Vagifem® (estradiol vaginal inserts) 10 mcg, a medication used after menopause to treat moderate to severe menopausal changes in and around the vagina.
Imvexxy 10mcg vaginal inserts(estradiol 雌二醇阴道插入物)[/caption]药店国别:产地国家:美国处 方药:是所属类别:10微克/支 18支包装规格:10微克/支 18支计价单位:盒生产厂家中文参考译名:TherapeuticsMD生产厂家英文名:TherapeuticsMD原产地英文商品名:IMVEXXY 10mcg 18vaginal inserts原产地英文药品名:estradiol中文...
Estradiol vaginal tablet (Vagifem): Initially, 25 mcg once daily for 2 weeks; maintenance, 25 mcg twice weekly.Estradiol vaginal cream (Estrace): Initially, 2–4 g of 0.01% cream daily for 1–2 weeks; reduce to one-half the initial dosage for 2 weeks. Maintenance, 1 g 1 to 3 times...
10. Shumaker SA, et al. Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women. JAMA. 2004;291:2947-2958. PATIENT INFORMATION Estradiol Vaginal Cream, USP(es" tra dye' ol) Read this Patient Information before you start using estradio...
(17b)-3-Hydroxyestra-1(10),2,4-trien-17-yl Pentanoate; (17Β)-3-hydroxyestra-1(10),2,4-trien-17-yl pentanoate; (17Β)-3-Hydroxyestra-1(10),2,4-trien-17-yl valerate; (17Β)-3-hydroxyestra-1,3,5(10)-trien-17-yl pentanoate; (8R,9S,13S,14S,17S)-3-hydroxy-13-met...
Imvexxy 4mcg vaginal inserts(estradiol 雌二醇阴道插入物)[/caption]药店国别:产地国家:美国处 方药:是所属类别:4微克/支 18支包装规格:4微克/支 18支计价单位:盒生产厂家中文参考译名:TherapeuticsMD生产厂家英文名:TherapeuticsMD原产地英文商品名:IMVEXXY 4mcg 18vaginal inserts原产地英文药品名:estradiol中文参考...
Vagifem 10mcg Novo Nordisk, Switzerland Vagifem 25mcg Novo Nordisk, Switzerland Vivelle Dot Novartis, Belgium; Novartis, Denmark Vivelledot Sandoz, France Wellnara 1mg/0,04mg [+ Levonorgestrel] Jenapharm, Germany Zoely [+ Nomegestrol] Delpharm, Georgia; Merck Sharp & Dohme, Australia; Merck Sharp...
Genitourinary: Breast cyst (≤10%), breast hypertrophy (≤10%), breast swelling (≤10%), breast tenderness (≤10%), mastalgia (≤10%), nipple discharge (≤10%), dysmenorrhea (≤9%), vaginal infection (7% to 8%), genital discharge (3% to 7%), vulvovaginal infection (4%) ...
Transdermal patch, vaginal ring, injection: Start on the day the next dose would have been due IUD or implant: Start on the day of removal Use after childbirth (in women who are not breast-feeding) or after second trimester abortion: Therapy may be started ≥4 weeks postpartum. Pregnancy ...